Growing community of inventors

Mölndal, Sweden

Mikael Dahlström

Average Co-Inventor Count = 2.99

ph-index = 3

The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.

Forward Citations = 125

Mikael DahlströmIngemar Starke (5 patents)Mikael DahlströmStaffan Po Karlsson (4 patents)Mikael DahlströmSusanne Alenfalk (4 patents)Mikael DahlströmFana Hunegnaw (4 patents)Mikael DahlströmMalin Anita Lemurell (3 patents)Mikael DahlströmAkinori Tatara (2 patents)Mikael DahlströmGanapati Bhat (2 patents)Mikael DahlströmAnn-Margret Lindqvist (2 patents)Mikael DahlströmJohnson M Coutinho (2 patents)Mikael DahlströmMichael Lofthagen (2 patents)Mikael DahlströmDavid Blomberg (1 patent)Mikael DahlströmTore Skjaret (1 patent)Mikael DahlströmBo Lindqvist (1 patent)Mikael DahlströmTore Skjäret (1 patent)Mikael DahlströmArne Brändström (1 patent)Mikael DahlströmMikael Dahlström (10 patents)Ingemar StarkeIngemar Starke (56 patents)Staffan Po KarlssonStaffan Po Karlsson (15 patents)Susanne AlenfalkSusanne Alenfalk (4 patents)Fana HunegnawFana Hunegnaw (4 patents)Malin Anita LemurellMalin Anita Lemurell (13 patents)Akinori TataraAkinori Tatara (11 patents)Ganapati BhatGanapati Bhat (5 patents)Ann-Margret LindqvistAnn-Margret Lindqvist (3 patents)Johnson M CoutinhoJohnson M Coutinho (3 patents)Michael LofthagenMichael Lofthagen (3 patents)David BlombergDavid Blomberg (6 patents)Tore SkjaretTore Skjaret (4 patents)Bo LindqvistBo Lindqvist (3 patents)Tore SkjäretTore Skjäret (1 patent)Arne BrändströmArne Brändström (1 patent)
..
Inventor’s number of patents
..
Strength of working relationships

Company Filing History:

1. Astrazeneca Ab (8 from 1,500 patents)

2. Elobix Ab (2 from 10 patents)


10 patents:

1. 10995115 - Process for the preparation of 1,5-benzothiazepine compounds

2. 10428109 - Process for the preparation of 1,5-benzothiazepine compounds

3. 7906502 - 2-azetidinone derivatives as cholesterol absorption inhibitors for the treatment of hyperlipidaemic conditions

4. 7893048 - 2-azetidinone derivatives as cholesterol absorption inhibitors for the treatment of hyperlipidaemic conditions

5. 7871998 - Diphenylazetidinone derivatives possessing cholesterol absorption inhibitory activity

6. 7863265 - 2-azetidinone derivatives and their use as cholesterol absorption inhibitors for the treatment of hyperlipidaemia

7. 7560472 - Salts of omeprazole and esomeprazole II

8. 7345061 - Alkylammonium salts of omeprazole and esomeprazole

9. 7326724 - Salts of omeprazole and esomeprazole I

10. 7192945 - Benzothiazepine derivatives

Please report any incorrect information to support@idiyas.com
idiyas.com
as of
12/6/2025
Loading…